A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer.
作者： Sang Hoon Ji , Do Hyoung Lim , Seong Yoon Yi , Hyo Song Kim , Hyun Jung Jun
关键词:
摘要: Background Because treatment of advanced gastric cancer (AGC) patients after failure with first-line chemotherapy remains controversial, we performed this retrospective analysis based on the data obtained from 1455 registered in a cohort respect to receiving or not subsequent chemotherapy.
core.ac.uk
doaj.org
biomedcentral.com
springer.com参考文章(17)
Se Hoon Park, Won Ki Kang, Hyo Rak Lee, Jinny Park, Kyung-Eun Lee, Se Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Chung, Young-Hyuk Im, Mark H Lee, Chan H Park, Keunchil Park, None, Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen. American Journal of Clinical Oncology. ,vol. 27, pp. 477- 480 ,(2004) , 10.1097/01.COC.0000136018.81814.79
S Pyrhönen, T Kuitunen, P Nyandoto, M Kouri, Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. British Journal of Cancer. ,vol. 71, pp. 587- 591 ,(1995) , 10.1038/BJC.1995.114
Se Hoon Park, Young Saing Kim, Junshik Hong, Jinny Park, Eunmi Nam, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon Kee Lee, Min Chung, Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study. Anti-Cancer Drugs. ,vol. 19, pp. 303- 307 ,(2008) , 10.1097/CAD.0B013E3282F46AD8
Dong Il Park, Jung Won Yun, Jung Ho Park, Suk Joong Oh, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Chang Hak Yoo, Byung Ho Son, Eun Yoon Cho, Seoung Wan Chae, Eo-Jin Kim, Jin Hee Sohn, Seung Ho Ryu, Antonia R. Sepulveda, HER-2 / neu Amplification Is an Independent Prognostic Factor in Gastric Cancer Digestive Diseases and Sciences. ,vol. 51, pp. 1371- 1379 ,(2006) , 10.1007/S10620-005-9057-1
Gennaro Galizia, Eva Lieto, Michele Orditura, Paolo Castellano, Anna La Mura, Vincenzo Imperatore, Margherita Pinto, Anna Zamboli, Ferdinando De Vita, Francesca Ferraraccio, Epidermal Growth Factor Receptor (EGFR) Expression is Associated With a Worse Prognosis in Gastric Cancer Patients Undergoing Curative Surgery World Journal of Surgery. ,vol. 31, pp. 1458- 1468 ,(2007) , 10.1007/S00268-007-9016-4
Se Hoon Park, Jeeyun Lee, Se Hoon Lee, Joon Oh Park, Kihyun Kim, Won Seog Kim, Chul Won Jung, Young Suk Park, Won Ki Kang, Keunchil Park, Seonwoo Kim, Soo Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, None, Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer. Cancer Chemotherapy and Pharmacology. ,vol. 57, pp. 91- 96 ,(2006) , 10.1007/S00280-005-0027-2
D. Wilson, L. Hiller, J.I. Geh, Review of second-line chemotherapy for advanced gastric adenocarcinoma Clinical Oncology. ,vol. 17, pp. 81- 90 ,(2005) , 10.1016/J.CLON.2004.10.006
J Matsubara, T Nishina, Y Yamada, T Moriwaki, T Shimoda, T Kajiwara, T E Nakajima, K Kato, T Hamaguchi, Y Shimada, Y Okayama, T Oka, K Shirao, Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer British Journal of Cancer. ,vol. 98, pp. 832- 839 ,(2008) , 10.1038/SJ.BJC.6604211
Eric van Cutsem, Daniel Haller, Atsushi Ohtsu, The role of chemotherapy in the current treatment of gastric cancer Gastric Cancer. ,vol. 5, pp. 17- 22 ,(2002) , 10.1007/S10120-002-0219-Y
Eva Lieto, Francesca Ferraraccio, Michele Orditura, Paolo Castellano, Anna La Mura, Margherita Pinto, Anna Zamboli, Ferdinando De Vita, Gennaro Galizia, Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) is an Independent Prognostic Indicator of Worse Outcome in Gastric Cancer Patients Annals of Surgical Oncology. ,vol. 15, pp. 69- 79 ,(2008) , 10.1245/S10434-007-9596-0